# CellType Landing Page Growth Score | YC W26

Lazyweb publishes a public search API over its indexed pages; the guide is at https://www.lazyweb.com/agent-access.

Source: https://www.lazyweb.com/yc-w26/celltype
Source observed: 2026-10-15T20:24:28.886Z
Last checked: 2026-10-20T08:04:44.688+00:00
Indexed: 2026-10-15T23:58:53.93+00:00

---

# CellType Landing Page Growth Score | YC W26

We assess [CellType](https://www.celltype.com/) in the YC W26 landing-page Growth Score workspace. CellType’s product positioning is **“The biological world model for drug development.”** Its supporting description says: “CellType learns the hidden structure of cellular and molecular state, then turns it into decision systems for drug development.”

## Overall score

- **Growth score:** **62/100**
- **Updated:** September 22, 2026
- **Weakest category:** **Trust — 52**
- **Category scores:** Trust 52, CTA 58, Value props 62, Mobile web 62, Information hierarchy 78

[Fix Trust](https://www.lazyweb.com/plans/checkout?plan=individual&source=growth_score_feature_build_fixes)

## How CellType ranks

1. [Recursion — 66](https://www.lazyweb.com/growth-score/site/recursion.com)
2. [Noetik — 66](https://www.lazyweb.com/growth-score/site/noetik.ai)
3. CellType — 62
4. [Insilico Medicine — 54](https://www.lazyweb.com/growth-score/site/insilico.com)
5. [Cellarity — 51](https://www.lazyweb.com/growth-score/site/cellarity.com)
6. [Deep Genomics — 48](https://www.lazyweb.com/growth-score/site/deepgenomics.com)

## Score over time

| Report date | Overall result | Change or note | Link |
| --- | ---: | --- | --- |
| September 22, 2026 | 62 | Live; overall +1, Value props −14, Information hierarchy +10 | — |
| May 19, 2026 | 61 | Overall −2, CTA −10 | [View report](https://www.lazyweb.com/growth-score/history/2026-05-19) |
| April 13, 2026 | 63 | First tracked report; strongest Value props 76, weakest Trust 52 | [View report](https://www.lazyweb.com/growth-score/history/2026-04-13) |

## Trust — 52, Fair

Trust measures proof that the product is real, competent, and safe to try.

![CellType trust capture](https://zlfyzdmohcskkucuunmk.supabase.co/storage/v1/object/public/sites/growth-score/site/celltype.com.jpg?v=2026-09-22T20%3A06%3A49.073%2B00%3A00)

The comparison reads identify the following trust signals:

| Company | Trust read |
| --- | --- |
| CellType | Banner: “CellType signs major strategic partnership with Senhwa Biosciences” |
| Recursion | “Unlocking the First Neuroscience Target for the Recursion and Genentech Collaboration” |
| Insilico Medicine | Pipeline rows showing “Out-licensed to Exelixis” and “Out-licensed to Menarini,” with Phase I–III progress bars; the supplied text ends after “and”. |
| Cellarity | No visible trust signal identified. |
| Deep Genomics | No visible trust signal identified. |
| Noetik | Tissue data visualization with labeled gene markers: IFNG, GZMB, PDCD1, IL7R |

Trust ranking:

1. [Insilico Medicine — 72](https://www.lazyweb.com/growth-score/site/insilico.com)
2. [Recursion — 58](https://www.lazyweb.com/growth-score/site/recursion.com)
3. CellType — 52
4. [Noetik — 42](https://www.lazyweb.com/growth-score/site/noetik.ai)
5. [Cellarity — 38](https://www.lazyweb.com/growth-score/site/cellarity.com)
6. [Deep Genomics — 38](https://www.lazyweb.com/growth-score/site/deepgenomics.com)

[Build proof section](https://www.lazyweb.com/backlog?site=celltype.com#opt-trust-signals) to choose proof signals and receive copy and placement for a stronger trust section.

## CTA — 58, Fair

This category evaluates CTA copy, size, verb, and cost-feel. CellType’s primary CTA is **“Request Access.”** The identified problems are:

- “Request” signals a gated, costly click.
- It is a text link with no button footprint.
- It is visually dwarfed by the headline.
- There is no secondary CTA fallback.

CTA ranking:

1. [Recursion — 68](https://www.lazyweb.com/growth-score/site/recursion.com)
2. [Noetik — 68](https://www.lazyweb.com/growth-score/site/noetik.ai)
3. CellType — 58
4. [Insilico Medicine — 44](https://www.lazyweb.com/growth-score/site/insilico.com)
5. [Cellarity — 44](https://www.lazyweb.com/growth-score/site/cellarity.com)
6. [Deep Genomics — 30](https://www.lazyweb.com/growth-score/site/deepgenomics.com)

[Rewrite this CTA](https://www.lazyweb.com/backlog?site=celltype.com#opt-cta-writing) to generate primary and secondary CTA options grounded in CellType’s offer and visitor objections.

## Value props — 62, Fair

CellType’s headline is marked **vague**:

> The biological world model for drug development

### Working

- Names the audience: drug development.
- The broad category claim signals ambition.
- The partnership banner adds credibility.

### Could improve

- No outcome or benefit is stated.
- There are zero numbers or proof points.
- The hero blob shows nothing about the product.

Value-prop ranking:

1. [Recursion — 68](https://www.lazyweb.com/growth-score/site/recursion.com)
2. [Insilico Medicine — 64](https://www.lazyweb.com/growth-score/site/insilico.com)
3. CellType — 62
4. [Noetik — 62](https://www.lazyweb.com/growth-score/site/noetik.ai)
5. [Deep Genomics — 58](https://www.lazyweb.com/growth-score/site/deepgenomics.com)
6. [Cellarity — 48](https://www.lazyweb.com/growth-score/site/cellarity.com)

## Mobile web — 62, Fair

The mobile review identifies two issues:

![Mobile web annotations on the mobile capture](https://zlfyzdmohcskkucuunmk.supabase.co/storage/v1/object/public/sites/growth-score/site/celltype.com-mobile.jpg?v=2026-09-22T20%3A06%3A49.073%2B00%3A00)

1. **Request Access link:** The primary CTA is plain text cropped at the fold edge rather than a visible, thumb-sized button.
2. **Hero headline block:** The desktop-scale headline wraps into four tall lines, pushing the CTA out of the first viewport.

[View mobile fixes](https://www.lazyweb.com/backlog?site=celltype.com#opt-mobile-web) to convert these findings into a prioritized implementation checklist.

## Information hierarchy — 78, Fair

![Information hierarchy annotations on the desktop capture](https://zlfyzdmohcskkucuunmk.supabase.co/storage/v1/object/public/sites/growth-score/site/celltype.com.jpg?v=2026-09-22T20%3A06%3A49.073%2B00%3A00)

1. **Request Access link:** The primary CTA is body-weight text with no button treatment, making it the quietest element on a page intended to drive access requests.
2. **Partnership banner:** A full-width black banner with an outbound link has stronger contrast than the CTA and appears first in the scan path.
3. **Orb overlaps headline:** The sphere’s edge collides with “development,” muddying the headline’s final word rather than framing it.
4. **Low-contrast navigation links:** Five grey links provide exits, and “Contact” fades toward illegibility against the background.

[View layout plan](https://www.lazyweb.com/backlog?site=celltype.com#opt-information-hierarchy) to turn these callouts into a sequenced keep, move, merge, or remove plan.

## Competitors

The competitor set is inferred from product, audience, and value proposition:

1. [Recursion — recursion.com — 66](https://www.lazyweb.com/growth-score/site/recursion.com)
2. [Noetik — noetik.ai — 66](https://www.lazyweb.com/growth-score/site/noetik.ai)
3. CellType — 62
4. [Insilico Medicine — insilico.com — 54](https://www.lazyweb.com/growth-score/site/insilico.com)
5. [Cellarity — cellarity.com — 51](https://www.lazyweb.com/growth-score/site/cellarity.com)
6. [Deep Genomics — deepgenomics.com — 48](https://www.lazyweb.com/growth-score/site/deepgenomics.com)

---

[Read this page’s summary](https://www.lazyweb.com/api/public/v1/page-tldr?url=https%3A%2F%2Fwww.lazyweb.com%2Fyc-w26%2Fcelltype&trace=t_bc7e1c4e5b07)

## Ask a follow-up about this page

Need a more specific answer? Ask the exact question you have. It returns a fresh, cited answer from Lazyweb’s knowledge base. No account or API key required.

Open this URL with your own question, URL-encoded. Only q is required. No account or setup.

`GET https://www.lazyweb.com/agent/faq?q={question}&trace=t_bc7e1c4e5b07`

[Tool guide and examples](https://www.lazyweb.com/agent-access) · [OpenAPI](https://www.lazyweb.com/api/public/v1/openapi.json) · [Page TLDR form](https://www.lazyweb.com/agent-tools/page-tldr?url=https%3A%2F%2Fwww.lazyweb.com%2Fyc-w26%2Fcelltype). Opening a form does not execute a tool.